325 related articles for article (PubMed ID: 20699475)
1. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.
Ramadani F; Bolland DJ; Garcon F; Emery JL; Vanhaesebroeck B; Corcoran AE; Okkenhaug K
Sci Signal; 2010 Aug; 3(134):ra60. PubMed ID: 20699475
[TBL] [Abstract][Full Text] [Related]
2. B cell receptor signaling: picky about PI3Ks.
Limon JJ; Fruman DA
Sci Signal; 2010 Aug; 3(134):pe25. PubMed ID: 20699473
[TBL] [Abstract][Full Text] [Related]
3. Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation.
Al-Alwan MM; Okkenhaug K; Vanhaesebroeck B; Hayflick JS; Marshall AJ
J Immunol; 2007 Feb; 178(4):2328-35. PubMed ID: 17277138
[TBL] [Abstract][Full Text] [Related]
4. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
[TBL] [Abstract][Full Text] [Related]
5. The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.
Beer-Hammer S; Zebedin E; von Holleben M; Alferink J; Reis B; Dresing P; Degrandi D; Scheu S; Hirsch E; Sexl V; Pfeffer K; Nürnberg B; Piekorz RP
J Leukoc Biol; 2010 Jun; 87(6):1083-95. PubMed ID: 20200404
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the individual contributions of Igalpha (CD79a)- and Igbeta (CD79b)-mediated tonic signaling for bone marrow B cell development and peripheral B cell maturation.
Fuentes-Pananá EM; Bannish G; Karnell FG; Treml JF; Monroe JG
J Immunol; 2006 Dec; 177(11):7913-22. PubMed ID: 17114463
[TBL] [Abstract][Full Text] [Related]
7. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.
Bilancio A; Okkenhaug K; Camps M; Emery JL; Ruckle T; Rommel C; Vanhaesebroeck B
Blood; 2006 Jan; 107(2):642-50. PubMed ID: 16179367
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.
Glassford J; Vigorito E; Soeiro I; Madureira PA; Zoumpoulidou G; Brosens JJ; Turner M; Lam EW
Eur J Immunol; 2005 Sep; 35(9):2748-61. PubMed ID: 16114097
[TBL] [Abstract][Full Text] [Related]
9. P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse.
Iyengar S; Clear A; Bödör C; Maharaj L; Lee A; Calaminici M; Matthews J; Iqbal S; Auer R; Gribben J; Joel S
Blood; 2013 Mar; 121(12):2274-84. PubMed ID: 23341541
[TBL] [Abstract][Full Text] [Related]
10. The PI3K p110delta is required for down-regulation of RAG expression in immature B cells.
Llorian M; Stamataki Z; Hill S; Turner M; Mårtensson IL
J Immunol; 2007 Feb; 178(4):1981-5. PubMed ID: 17277100
[TBL] [Abstract][Full Text] [Related]
11. Role of PI3K in the generation and survival of B cells.
Werner M; Hobeika E; Jumaa H
Immunol Rev; 2010 Sep; 237(1):55-71. PubMed ID: 20727029
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of P110α and P110δ catalytic subunits of PI3 kinase reverses impaired arterial healing after injury in hypercholesterolemic male mice.
Chaudhuri P; Smith AH; Graham LM; Rosenbaum MA
Am J Physiol Cell Physiol; 2021 Jun; 320(6):C943-C955. PubMed ID: 33689479
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.
So L; Yea SS; Oak JS; Lu M; Manmadhan A; Ke QH; Janes MR; Kessler LV; Kucharski JM; Li LS; Martin MB; Ren P; Jessen KA; Liu Y; Rommel C; Fruman DA
J Biol Chem; 2013 Feb; 288(8):5718-31. PubMed ID: 23275335
[TBL] [Abstract][Full Text] [Related]
14. Synthetic biology of B cell activation: understanding signal amplification at the B cell antigen receptor using a rebuilding approach.
Kulathu Y; Zuern C; Yang J; Reth M
Biol Chem; 2019 Mar; 400(4):555-563. PubMed ID: 30465710
[TBL] [Abstract][Full Text] [Related]
15. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
Okkenhaug K; Bilancio A; Farjot G; Priddle H; Sancho S; Peskett E; Pearce W; Meek SE; Salpekar A; Waterfield MD; Smith AJ; Vanhaesebroeck B
Science; 2002 Aug; 297(5583):1031-4. PubMed ID: 12130661
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
Papakonstanti EA; Zwaenepoel O; Bilancio A; Burns E; Nock GE; Houseman B; Shokat K; Ridley AJ; Vanhaesebroeck B
J Cell Sci; 2008 Dec; 121(Pt 24):4124-33. PubMed ID: 19033389
[TBL] [Abstract][Full Text] [Related]
17. RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.
Bednarski JJ; Pandey R; Schulte E; White LS; Chen BR; Sandoval GJ; Kohyama M; Haldar M; Nickless A; Trott A; Cheng G; Murphy KM; Bassing CH; Payton JE; Sleckman BP
J Exp Med; 2016 Feb; 213(2):209-23. PubMed ID: 26834154
[TBL] [Abstract][Full Text] [Related]
18. Activity of any class IA PI3K isoform can sustain cell proliferation and survival.
Foukas LC; Berenjeno IM; Gray A; Khwaja A; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11381-6. PubMed ID: 20534549
[TBL] [Abstract][Full Text] [Related]
19. The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.
Janas ML; Hodson D; Stamataki Z; Hill S; Welch K; Gambardella L; Trotman LC; Pandolfi PP; Vigorito E; Turner M
J Immunol; 2008 Jan; 180(2):739-46. PubMed ID: 18178811
[TBL] [Abstract][Full Text] [Related]
20. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
Guillermet-Guibert J; Bjorklof K; Salpekar A; Gonella C; Ramadani F; Bilancio A; Meek S; Smith AJ; Okkenhaug K; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8292-7. PubMed ID: 18544649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
